Biofrontera AG (ETR:B8FK)
Germany · Delayed Price · Currency is EUR 2.520
+0.030 (1.20%)
Apr 17, 2026, 5:43 PM CET
Biofrontera AG Market Cap
Biofrontera AG has a market cap or net worth of €15.56 million as of April 17, 2026. Its market cap has increased by 3.02% in one year.
Market Cap
15.56M
Enterprise Value
12.63M
Revenue
13.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.52
Market Cap Chart
Since October 31, 2006, Biofrontera AG's market cap has decreased from 38.05M to 15.56M, a decrease of -59.11%. That is a compound annual growth rate of -4.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 15.56M | 4.92% |
| Dec 30, 2025 | 14.83M | 13.49% |
| Dec 30, 2024 | 13.07M | -48.94% |
| Dec 29, 2023 | 25.59M | -73.70% |
| Dec 30, 2022 | 97.31M | 15.92% |
| Dec 30, 2021 | 83.94M | -42.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 50.06B |
| Siemens Healthineers AG | 42.79B |
| Bayer Aktiengesellschaft | 39.97B |
| Fresenius SE & Co. KGaA | 25.13B |
| DocCheck AG | 63.93M |
| Pentixapharm Holding AG | 50.31M |
| MeVis Medical Solutions AG | 41.50M |
| Maternus-Kliniken Aktiengesellschaft | 24.33M |